Abstract
IntroductionClinical guidelines recommend non-vitamin K antagonist oral anticoagulants (NOACs) over vitamin K antagonists (VKAs) for stroke prevention in most patients with atrial fibrillation (AF). Frail elderly were under-represented in the...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have